A Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects

NCT04288687 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Prostate Adenocarcinoma

Interventions

DRUG: Niraparib Pill

Sponsor

Abramson Cancer Center at Penn Medicine